Periodic Reporting for period 4 - MiniEmbryoBlueprint (The mammalian body plan blueprint, an in vitro approach)
Okres sprawozdawczy: 2024-02-01 do 2025-09-30
The gastruloid system has proven an excellent model system of gastrulation and one that has shown to reduce the use of animals in research. At this, the system has a strong impact on the 3Rs (Replacement, Reduction and Refinement) in the use of animals in research. Most significantly, we have shown that we can obtain gastruloids from human ES cells and this has opened up an avenue to explore the early stages of human development, something that has remained impossible to do. This is turn will allow disease modelling of multiple neonatal conditions. An important aspect of gastruloids is the fact that they are compliant with all ethical rules of research with human embryos. The project does not include working with human gastruloids but an request has been made to do this on the grounds of the significance and potential of the research.
Analysis of gene expression in embryos of different species has shown that the two modules are conserved in all amniotes and that in all cases the transition coincides with the decay of Nodal signalling and the increase in Wnt signalling. This indicates that the two modules represent a conserved and universal feature of amniote gastrulation. Furthermore, we have shown the existence and function of both modules in human gastruloids, suggesting that they are likely to be functional in human embryos.
Additional outputs of the project are
• The standardization of the gastruloid culture that is now widely used to study early mammalian development with a significant reduction in the number of animals in experiments.
• A major contribution to the development of a replica model of primate gastrulation in a collaboration with Zhen Liu in Shanghai (China).
• Collaborations that have shown how gastruloids are a platform for disease modelling during somitogenesis and early blood formation.
• Significant contributions to the development of standards and an ethical framework for the field of stem cell based embryo models.
The results are being extrapolated to human gastruloids where they can be used to establish platforms for disease modelling and drug screening.